NewAmsterdam Pharma Company N.V.
NAMSNASDAQ
Healthcare
Biotechnology
$33.90
+0.91(2.8%)
52W $14.90 – $41.45
Quick:
8-K
Mar 2, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-K
Feb 18, 2026 (1 months ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
8-K
Feb 18, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Feb 17, 2026 (1 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G
Feb 5, 2026 (2 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Jan 9, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13D/A
Dec 4, 2025 (4 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
SCHEDULE 13G/A
Nov 13, 2025 (4 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13D/A
Nov 7, 2025 (5 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
10-Q
Nov 5, 2025 (5 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Nov 5, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13D/A
Nov 4, 2025 (5 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
SCHEDULE 13D/A
Sep 30, 2025 (6 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
8-K
Sep 2, 2025 (7 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13D/A
Aug 20, 2025 (7 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
8-K
Aug 18, 2025 (7 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Aug 15, 2025 (7 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Aug 13, 2025 (7 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13D/A
Aug 12, 2025 (7 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
8-K
Aug 6, 2025 (8 months ago)Current Report
Material event disclosure
Event materiality and market reaction